Biohaven Advances Pivotal Phase 3 Trial for Graves’ Disease
New Haven, Connecticut, USA, November 5, 2026 Biohaven Ltd. has announced continued progress in its research programme for Graves’...
Phase 3 Clinical Trial
Advertisement
Alfasigma Wins EU Approval for Filgotinib in axSpA
Milan, Italy, November 5, 2026 Alfasigma S.p.A., a global pharmaceutical company focused on innovative treatments for specialty care and...
SK Biopharmaceuticals Seeks FDA Expansion for Cenobamate
Paramus, New Jersey, United States, November 4, 2026 SK Biopharmaceuticals Co., Ltd. has submitted a supplemental New Drug Application...
Pentixapharm Advances Phase 3 PANDA Radiopharmaceutical Study
Berlin, Germany, November 4, 2026 Pentixapharm Holding AG has announced significant progress in preparations for its pivotal Phase 3...
Merck Launches Phase 3 Trial of OHTUVAYRE for COPD
Rahway, New Jersey, USA, November 3, 2026 Merck & Co. has initiated a new Phase 3 clinical trial evaluating...
Advertisements
Nuvation Bio Expands Phase 3 Safusidenib Trial Across Europe
NEW YORK, U.S., October 29, 2026 Nuvation Bio Inc. has announced the expansion of its pivotal Phase 3 SIGMA...
Novavax Earns $125M as Sanofi Starts Phase 3 Vaccine Trial
GAITHERSBURG, Maryland, October 29, 2026 Novavax, Inc. has announced that it has earned a $125 million milestone payment from...
Sobi Reports Positive Phase 3 Pozdeutinurad Gout Data
STOCKHOLM, Sweden, October 29, 2026 Swedish Orphan Biovitrum AB (Sobi) has announced positive late-breaking results from its pivotal Phase...
US WorldMeds Acquires Orbus to Advance Glioma Drug Research
LOUISVILLE, Kentucky, and MENLO PARK, California, October 27, 2026 US WorldMeds Ventures, LLC has acquired Orbus Therapeutics, Inc., through...
Eli Lilly Retatrutide Shows Strong Phase 3 Diabetes Results!
INDIANAPOLIS, October 28, 2026 Eli Lilly and Company has announced positive topline results from its Phase 3 TRANSCEND-T2D-2 clinical...
Advertisement
